Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03319849 |
|---|---|
| Brief Title: | A Study to Determine the Safety and Efficacy of Renexus® in Macular Telangiectasia Type 2 |
| First Submitted : | October 3, 2017 |
| First Submitted that Met QC Criteria : | October 19, 2017 |
| First Posted : | October 24, 2017 |
| Last Update Submitted that Met QC Criteria : | January 8, 2020 |
| Last Update Posted : | January 13, 2020 (Estimate) |